English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 855234      Online Users : 1016
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/5937


    Title: Sintered dicalcium pyrophosphate decreases bone turnover rate in osteoporotic rat: A study on serum biochemical bone turnover markers
    Authors: Yang, KC;Yen, KC;Huang, JY;Wu, CC;Lin, FH
    Contributors: Division of Medical Engineering Research
    Abstract: Sintered dicalcium pyrophosphate (SDCP) is a synthetic pyrophosphate analog that could be utilized in the treatment for osteoporosis. In this study, an ovariectomized (OVX) Wistar rat model is applied to evaluate the effects of SDCP on biochemical bone turnover markers relative to its effects on bone mass. OVX rats were treated with SDCP in the dose of 0.75 mg/kg daily for continued 13weeks. Rats were sacrificed after predetermined periods; serum levels of bone turnover markers were evaluated. Parallel histological evaluation and bone ashes of the long bones of four limbs were performed. Results showed that the serum level of bone resorption marker (type I collagen fragments) for rats treated with SDCP decreased, and the levels of bone formation markers (alkaline phosphatase [ALP], osteocalcin and osteopontin) also decreased significantly.These findings reveal the bone turnover rate decreased. Histological examinations of distal femoral metaphysis revealed the OVX rats ingested with SDCP restored the architectures of trabecular bone and decreased the porosity. This finding was consistent with the increase in serum tartrate-resistant acid phosphatase 5b level, an indicator that represents the number of osteoclast, which indicates an increase of bony tissues. The analyses of limbs bone ashes showed a significant increase in bone mineral contents. This study indicates that the SDCP inhibits the bone resorption rate to restore the bone mass in the OVX rats that could be applied in clinic in the future.
    Date: 2011-01
    Relation: Biomedicine and Aging Pathology. 2011 Jan;1(1):46-51.
    Link to: http://dx.doi.org/10.1016/j.biomag.2010.10.004
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=79960459635
    Appears in Collections:[林峯輝] 期刊論文

    Files in This Item:

    File Description SizeFormat
    SCP79960459635.pdf792KbAdobe PDF412View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback